
RCC Treatment Decision-Making Requires a Balance of Efficacy and Individual Patient Considerations
The frontline treatment landscape for renal cell carcinoma (RCC) has progressed substantially with the introduction of combination therapies that have driven an increase in disease control in the up-front setting, according to Marc R. Matrana, MD, who …